Sapan Ghai, CCO at Sovereign Metals, discusses their superior graphite test results. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPlant Health Regulatory News (PHC)

Share Price Information for Plant Health (PHC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 4.20
Bid: 4.14
Ask: 4.20
Change: -0.35 (-7.69%)
Spread: 0.06 (1.449%)
Open: 4.32
High: 4.32
Low: 4.20
Prev. Close: 4.55
PHC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Results of General Meeting

16 Mar 2020 11:53

RNS Number : 2831G
Plant Health Care PLC
16 March 2020
 

16 March 2020

 

Plant Health Care plc

("Plant Health Care", "PHC" or the "Company")

 

Results of General Meeting, Total Voting Rights and PDMR shareholding

 

Plant Health Care (AIM: PHC), a leading provider of novel patent-protected biological products to global agricultural markets, confirms that, at the Company's General Meeting held in London today, all resolutions put to the meeting were duly passed.

Application has been made to the London Stock Exchange for 44,602,188 new ordinary shares ("New Ordinary Shares") of 1 pence each to be admitted to trading on AIM ("Admission") pursuant to the Placing and Subscription. The New Ordinary Shares will rank pari passu with the Company's existing issued share capital.

All conditions of the Fundraising, except for Admission, set out in the Company's announcement on 24 February 2020, have now been met and it is expected that Admission will become effective and that dealings in the New Ordinary Shares on AIM will commence at 8.00 a.m. on 18 March 2020.

Total Voting Rights

In conformity with the FCA's Disclosure Guidance and Transparency Rules, the Company confirms that following the Admission of the placing and subscription shares, its issued share capital consists of 251,989,569 ordinary shares of 1 pence each. All of the Ordinary Shares have equal voting rights and there are no Ordinary Shares held in treasury. This figure of 251,989,569 Ordinary Shares represents the total voting rights in the Company and may be used by shareholders as the denominator for the calculations by which they can determine if they are required to notify their interest in, or a change to their interest in, the Company under the Rules.

 

Capitalised terms in this Announcement shall have the same meanings given to such terms in the Company's announcement at 7.00 a.m. on 24 February 2020.

 

For further information, please contact:

 

Plant Health Care plc

Tel: +1 919 926 1600

 

Chris Richards, CEO

 

Arden Partners plc - Nomad & Broker

Tel: +44 (0) 20 7614 5900

 

John Llewellyn-Lloyd / Dan Gee-Summons

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Chris Richards (Chief Executive Officer)

Richard Webb (Non-Executive Chairman)

Jeffrey Tweedy (Chief Operating Officer)

Jeffrey Hovey (Chief Financial Officer)

William Lewis (Non-Executive Director)

2

Reason for the notification

a)

Position/status

 See 1 a) above

b)

Initial notification/ Amendment

 Initial Notification

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

 Plant Health Care plc

b)

LEI

213800KBQPJZ2FM8QH27

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 Identification code

 Ordinary Shares of 1 pence each

 

 ISIN GB00B01JC540

 

b)

Nature of the transactions

 Subscription for new ordinary shares pursuant to the Fundraising

c)

Price(s) and volume(s)

Director/PDMR

Price(s)

 

Volume(s)

Chris Richards

8p

500,000

Richard Webb

8p

250,000

Jeffrey Tweedy

8p

48,460

Jeffrey Hovey

8p

29,076

William Lewis

8p

193,843

d)

Aggregated information

- Aggregated volume

- Price

 

1,021,379

£81,710.32

e)

Date of the transaction

 18 March 2020

f)

Place of the transaction

 London Stock Exchange (XLON)

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
ROMSFDFFMESSELD
Date   Source Headline
8th May 20247:00 amRNSTrading Update
22nd Apr 20247:00 amRNSApproval of Harpinαβ in Belgium
16th Apr 20247:00 amRNSPlant Health Care--China Distribution with AMVAC
4th Apr 20247:00 amRNSApproval of PHC68949 in Mexico
4th Mar 20241:55 pmRNSHolding(s) in Company
24th Jan 20244:27 pmRNSHolding(s) in Company
2nd Jan 20247:00 amRNSBrazil approves TEIKKOâ„¢
20th Dec 20237:00 amRNSBoard Changes and Grant of Options
19th Dec 20233:34 pmRNSHolding(s) in Company
30th Nov 20231:45 pmRNSHolding(s) in Company
28th Nov 20233:16 pmRNSHolding(s) in Company
27th Nov 20234:03 pmRNSHolding(s) in Company
27th Nov 20231:27 pmRNSHolding(s) in Company
24th Nov 20234:19 pmRNSDirector/PDMR Shareholding
24th Nov 202310:57 amRNSDirector/PDMR Shareholding
23rd Nov 20232:31 pmRNSHolding(s) in Company
22nd Nov 20237:00 amRNSTrading Update
31st Oct 20237:00 amRNSChange of Adviser
20th Oct 20237:00 amRNSHolding(s) in Company
3rd Oct 20236:28 pmRNSPlant Health Care PREtec Product with Agrii UK
28th Sep 20237:00 amRNSNew PREtec Products Announced
27th Sep 20237:00 amRNSUnaudited Interim Results
25th Sep 20237:00 amRNSPREtec Products Submitted for Regulatory Approval
31st Aug 20237:00 amRNSNotice of Results & Investor Presentation
18th Aug 20237:00 amRNSNew Product Regulatory Approval In Brazil
1st Aug 20237:00 amRNSApproval for Sale of Harpin aß Granted in Poland
24th Jul 20237:00 amRNSGrant of Options
12th Jul 202312:27 pmRNSHolding(s) in Company
30th Jun 20235:07 pmRNSNotification of Major Holdings
28th Jun 202312:29 pmRNSHolding(s) in Company
27th Jun 20234:08 pmRNSHolding(s) in Company
27th Jun 20231:08 pmRNSDirector Shareholding
23rd Jun 20237:00 amRNSResult of Fundraising
22nd Jun 20234:35 pmRNSFundraising to raise up to US$3.6 million
14th Jun 20237:00 amRNSWilbur Ellis Agreement
13th Jun 20231:43 pmRNSResult of AGM
30th May 20237:00 amRNSHolding(s) in Company
24th May 20231:12 pmRNSHolding(s) in Company
19th May 20235:55 pmRNSPublication of Annual Report and Notice of AGM
18th May 20237:00 amRNSResult of Consultation
9th May 20237:00 amRNSPHC68949 granted first stage of approval in Brazil
2nd May 20237:10 amRNSResults for the year ended 31 December 2022
12th Apr 20232:33 pmRNSNotice of Results
5th Apr 20235:29 pmRNSHolding(s) in Company
8th Mar 20232:45 pmRNSExercise of Options
2nd Mar 20237:00 amRNSBiofungicide PHC279 Approved by US EPA
1st Mar 20237:00 amRNSDirector/PDMR Shareholding
6th Feb 20237:00 amRNSTrading Statement
30th Jan 202312:08 pmRNSSignificant Shareholder
18th Jan 20237:00 amRNSBoard Appointments

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.